MaxImmun is a Horizon Europe project supported by the European Union, through the European Innovation Council
Grant agreement N°101129622
Start date : January 1, 2024
Duration : 48 months
An innovative therapeutic strategy to fight bacterial antibioresistance. Stay updated with the latest breakthroughs by joining our newsletter.
